Meet Biovian at the ‘Lyckad Läkemedelsutveckling’ seminar on 31 May 2012 at Hotel Grand, Stockholm, Sweden. Biovian’s director of business development and projects, Dr Knut Ringbom, will be available for in-depth disussions with delegates at Biovian’s stand.

A link for the event can be found here.

Biovian is a one-stop-shop that provides cGMP contract manufacturing of biopharmaceuticals. We offer a wide range of services from early development to aseptic fill and finish.

Biovian provides a full range of services including antigen isolation, cell line development, process development, cell cultivation, protein purification, and product fill and finish. Biovian’s cGMP facilities and state-of-the-art equipment enable flexible pilot production and development services.

Biovian is located in Finland, in the heart of Turku Science Park with excellent connections through both Turku and Helsinki international airports.

Biovian’s inspected 1,600m² cGMP facilities contain EU grade A, B, C and D class clean rooms and warehouses under full quality control, as well as extensively equipped development laboratories. Biovian holds manufacturing authorisation from NAM (Finnish National Agency for Medicines) and complies fully with the EU GMP. Biovian has biosafety level 1 and 2 laboratories and is capable of handling micro-organisms classified to GMM1 and GMM2. Biovian has been also inspected by the Finnish Board for Gene Technology.